PROF Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (15 Apr 2024 @ 16:00):

Stats
Today's Volume	32 834.00
Average Volume	40 987.00
Market Cap	192.99M
EPS	$0 ( 2024-03-07 )
Next earnings date	( $-0.310 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-5.85
ATR14	$0.0580 (0.73%)

Insider Trading

Date	Person	Action	Amount	type
2012-12-20	Hofer Michael	Sell	40 000	Patriot Minefinders Inc.
2012-12-18	Hofer Michael	Sell	40 000	Patriot Minefinders Inc.
2012-06-19	Tejada Fred	Buy	500 000	Common Shares
2012-06-19	Blanchet Justin	Buy	500 000	Common Shares
2012-06-19	Schweitzer John H.	Buy	500 000	Common Shares

INSIDER POWER
0.00
Last 8 transactions
Buy: 3 000 000 \| Sell: 80 000

Profound Medical Corp Correlation

10 Most Positive Correlations
MOMO	0.966
IMVT	0.958
BRAC	0.957
GLRE	0.957
FXCO	0.956
FMIV	0.955
MLCO	0.954
CBAY	0.953
ALXN	0.951
AVAC	0.951

10 Most Negative Correlations
PIII	-0.958
APOP	-0.953
SNPX	-0.949
GRIN	-0.947
CREG	-0.947
SWAV	-0.946
UTME	-0.945
OP	-0.944
SMIT	-0.944
LGMK	-0.941

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Profound Medical Corp Financials

Annual	2023
Revenue:	$7.33M
Gross Profit:	$4.46M (60.87 %)
EPS:	$-1.370

Q4	2023
Revenue:	$2.06M
Gross Profit:	$1.09M (52.71 %)
EPS:	$-0.430

Q3	2023
Revenue:	$1.73M
Gross Profit:	$1.06M (61.34 %)
EPS:	$-0.260

Q2	2023
Revenue:	$1.60M
Gross Profit:	$1.05M (65.54 %)
EPS:	$-0.350

Financial Reports:

No articles found.

Profound Medical Corp

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.